Cresanto Global Limited
Cresanto Global Limited (RAYMEDLABSLTD): company summary
Cresanto Global Limited (RAYMEDLABSLTD) is a micro-cap Healthcare company valued at ₹2 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
Cresanto Global Limited (RAYMEDLABSLTD) is a micro-cap Healthcare company valued at ₹2 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
- Recent price move
- Cresanto Global Limited last traded at ₹5.37, unchanged on the day.
- Financial performance
- Return on equity stands at 14.3%, a reasonable return on shareholder capital.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -0.72 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by momentum (7.5), but held back by risk (3.1). Scored on 3 of 5 measures.
DocStoX score
Low confidenceScored on 3 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Capital works hard — ROCE 128%
- Low leverage — D/E 0.00
- Loss-making in some of the last 5 years
- Small ₹2 cr company — thinner liquidity
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals & Biotechnology
Explore Cresanto Global Limited’s valuation
Free deep-dive tools · no sign-up
Cresanto Global Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Cresanto Global Limited with peers
Related tools & concepts
Value Cresanto Global Limited with the ratios and calculators DocStoX uses in its analysis.

